These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 28583146)

  • 1. The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study.
    Wanders JOP; Holland K; Karssemeijer N; Peeters PHM; Veldhuis WB; Mann RM; van Gils CH
    Breast Cancer Res; 2017 Jun; 19(1):67. PubMed ID: 28583146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
    Wanders JOP; van Gils CH; Karssemeijer N; Holland K; Kallenberg M; Peeters PHM; Nielsen M; Lillholm M
    Breast Cancer Res; 2018 May; 20(1):36. PubMed ID: 29720220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric breast density affects performance of digital screening mammography.
    Wanders JO; Holland K; Veldhuis WB; Mann RM; Pijnappel RM; Peeters PH; van Gils CH; Karssemeijer N
    Breast Cancer Res Treat; 2017 Feb; 162(1):95-103. PubMed ID: 28012087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment.
    Brand JS; Czene K; Shepherd JA; Leifland K; Heddson B; Sundbom A; Eriksson M; Li J; Humphreys K; Hall P
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1764-72. PubMed ID: 25012995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AI performance by mammographic density in a retrospective cohort study of 99,489 participants in BreastScreen Norway.
    Bergan MB; Larsen M; Moshina N; Bartsch H; Koch HW; Aase HS; Satybaldinov Z; Haldorsen IHS; Lee CI; Hofvind S
    Eur Radiol; 2024 Oct; 34(10):6298-6308. PubMed ID: 38528136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Cancer Risk and Mammographic Density Assessed with Semiautomated and Fully Automated Methods and BI-RADS.
    Jeffers AM; Sieh W; Lipson JA; Rothstein JH; McGuire V; Whittemore AS; Rubin DL
    Radiology; 2017 Feb; 282(2):348-355. PubMed ID: 27598536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast density and breast cancer-specific survival by detection mode.
    van der Waal D; Verbeek ALM; Broeders MJM
    BMC Cancer; 2018 Apr; 18(1):386. PubMed ID: 29618328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
    Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
    Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection.
    Chiarelli AM; Prummel MV; Muradali D; Shumak RS; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ
    Breast Cancer Res Treat; 2015 Nov; 154(2):377-87. PubMed ID: 26518019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital volumetric measurement of mammographic density and the risk of overlooking cancer in Japanese women.
    Sawada T; Akashi S; Nakamura S; Kuwayama T; Enokido K; Yoshida M; Hashimoto R; Ide T; Masuda H; Taruno K; Oyama H; Takamaru T; Kanada Y; Ikeda M; Kosugi N; Sato H; Nakayama S; Ata A; Tonouchi Y; Sakai H; Matsunaga Y; Matsutani A
    Breast Cancer; 2017 Sep; 24(5):708-713. PubMed ID: 28238177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and tumor characteristics of interval cancers by mammographic density.
    Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
    J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens.
    Hofvind S; Møller B; Thoresen S; Ursin G
    Int J Cancer; 2006 Jun; 118(12):3112-7. PubMed ID: 16395702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated and Clinical Breast Imaging Reporting and Data System Density Measures Predict Risk for Screen-Detected and Interval Cancers: A Case-Control Study.
    Kerlikowske K; Scott CG; Mahmoudzadeh AP; Ma L; Winham S; Jensen MR; Wu FF; Malkov S; Pankratz VS; Cummings SR; Shepherd JA; Brandt KR; Miglioretti DL; Vachon CM
    Ann Intern Med; 2018 Jun; 168(11):757-765. PubMed ID: 29710124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammographic density and interval cancers in mammographic screening: Moving towards more personalized screening.
    Larsen M; Lynge E; Lee CI; Lång K; Hofvind S
    Breast; 2023 Jun; 69():306-311. PubMed ID: 36966656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort.
    Olson JE; Sellers TA; Scott CG; Schueler BA; Brandt KR; Serie DJ; Jensen MR; Wu FF; Morton MJ; Heine JJ; Couch FJ; Pankratz VS; Vachon CM
    Breast Cancer Res; 2012 Nov; 14(6):R147. PubMed ID: 23152984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Volumetric Breast Density to Quantify the Potential Masking Risk of Mammographic Density.
    Destounis S; Johnston L; Highnam R; Arieno A; Morgan R; Chan A
    AJR Am J Roentgenol; 2017 Jan; 208(1):222-227. PubMed ID: 27824483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Clinical and Automated Breast Density Measurements: Implications for Risk Prediction and Supplemental Screening.
    Brandt KR; Scott CG; Ma L; Mahmoudzadeh AP; Jensen MR; Whaley DH; Wu FF; Malkov S; Hruska CB; Norman AD; Heine J; Shepherd J; Pankratz VS; Kerlikowske K; Vachon CM
    Radiology; 2016 Jun; 279(3):710-9. PubMed ID: 26694052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammographic density and breast cancer risk in breast screening assessment cases and women with a family history of breast cancer.
    Duffy SW; Morrish OWE; Allgood PC; Black R; Gillan MGC; Willsher P; Cooke J; Duncan KA; Michell MJ; Dobson HM; Maroni R; Lim YY; Purushothaman HN; Suaris T; Astley SM; Young KC; Tucker L; Gilbert FJ
    Eur J Cancer; 2018 Jan; 88():48-56. PubMed ID: 29190506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
    Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
    Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.
    Baré M; Torà N; Salas D; Sentís M; Ferrer J; Ibáñez J; Zubizarreta R; Sarriugarte G; Barata T; Domingo L; Castells X; Sala M
    Breast Cancer Res Treat; 2015 Nov; 154(2):403-15. PubMed ID: 26531756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.